These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21983493)

  • 1. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
    Bruno D; Pomara N; Nierenberg J; Ritchie JC; Lutz MW; Zetterberg H; Blennow K
    Exp Gerontol; 2012 May; 47(5):347-52. PubMed ID: 21983493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
    Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
    Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
    Langella S; Bonta K; Chen Y; Su Y; Vasquez D; Aguillon D; Acosta-Baena N; Baena AY; Garcia-Ospina G; Giraldo-Chica M; Tirado V; Muñoz C; Ríos-Romenets S; Guzman-Martínez C; Pruzin JJ; Ghisays V; Arboleda-Velasquez JF; Kosik KS; Tariot PN; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Res Ther; 2024 Oct; 16(1):208. PubMed ID: 39354618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
    Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
    Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.
    Bekris LM; Millard SP; Galloway NM; Vuletic S; Albers JJ; Li G; Galasko DR; DeCarli C; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Tsuang D; Peskind ER; Yu CE
    J Alzheimers Dis; 2008 Apr; 13(3):255-66. PubMed ID: 18430993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
    Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
    J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleó A; Johannsen P; Freund-Levi Y; Frölich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
    Alzheimers Dement; 2019 May; 15(5):644-654. PubMed ID: 30853464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25.
    Butt OH; Long JM; Henson RL; Herries E; Sutphen CL; Fagan AM; Cruchaga C; Ladenson JH; Holtzman DM; Morris JC; Ances BM; Schindler SE;
    Neurobiol Aging; 2021 Jun; 102():64-72. PubMed ID: 33765432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.
    Pomara N; Bruno D; Nierenberg JJ; Sidtis JJ; Martiniuk FT; Mehta PD; Zetterberg H; Blennow K
    Neurochem Res; 2011 Jun; 36(6):1124-8. PubMed ID: 21455713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CSF cortisol in AD is a function of APOE genotype.
    Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
    Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.